William Blair Comments on Krystal Biotech Q1 Earnings
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for Krystal Biotech in a research note issued to investors on Wednesday, February 19th. William Blair analyst S. Corwin forecasts that the company will post earnings per share of $1.91 for the quarter. The […]
